LEAH Labs is bringing cell therapies to dogs. Enabled by precision gene editing, we aim to use naturally occurring disease in dogs to iterate on and improve CAR-T cell therapy, while first targeting canine B cell lymphoma, a clinical analog of the CAR-T curable non-Hodgkin's lymphoma in humans.